3279-13-8 Usage
Uses
Used in Pharmaceutical Industry:
2-AMINO-4-CYCLOHEXYL-PHENOL is used as a chemical intermediate for the production of pharmaceuticals, contributing to the synthesis of various medicinal compounds. Its role in this industry is crucial for the development of new drugs and the improvement of existing ones.
Used in Dye Industry:
In the dye industry, 2-AMINO-4-CYCLOHEXYL-PHENOL serves as a chemical intermediate, playing a significant part in the creation of different types of dyes. Its properties allow for the production of dyes with specific characteristics, such as color intensity and stability.
Used in Organic Compounds Synthesis:
2-AMINO-4-CYCLOHEXYL-PHENOL is used as a chemical intermediate in the synthesis of other organic compounds, showcasing its versatility in chemical reactions and its ability to contribute to the formation of a wide range of chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 3279-13-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,2,7 and 9 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3279-13:
(6*3)+(5*2)+(4*7)+(3*9)+(2*1)+(1*3)=88
88 % 10 = 8
So 3279-13-8 is a valid CAS Registry Number.
3279-13-8Relevant academic research and scientific papers
Alkyl-substituted benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
-
, (2008/06/13)
A novel rifamycin derivative having the formula (I): STR1 wherein X1 is an alkyl group with 1 to 6 carbon atoms or a cycloalkyl group with 3 to 8 carbon atoms; X2 is a hydrogen atom or an alkyl group with 1 to 4 carbon atoms; R1 is hydrogen atom or acetyl group; A is a group represented by the formula: STR2 wherein R2 is an alkyl group with 1 to 4 carbon atoms or an alkoxyalkyl group with 2 to 6 carbon atoms and R3 is an alkyl group with 1 to 6 carbon atoms or an alkoxyalkyl group with 2 to 6 carbon atoms, or a group represented by the formula STR3 wherein STR4 is a 3 to 9 membered cyclic amino group with 2 to 8 carbon atoms, R4 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, or salts thereof, a process for preparing the same and antibacterial agents containing the same as an effective ingredient. The rifamycin derivative of the present invention having the formula (I) shows a strong antibacterial activity against the Gram-positive bacteria and the acid-fast bacteria.
